Atherosclerosis, vascular amyloidosis and brain hypoperfusion in the pathogenesis of sporadic Alzheimer's disease

Abstract We postulate that severe atherosclerotic occlusion of the circle of Willis and leptomeningeal arteries is an important factor in the pathogenesis of some sporadic Alzheimer's disease (AD) cases. These arterial stenoses are complicated by an overwhelming amyloid accumulation in the walls of leptomeningeal and cortical arteries resulting in a significant decrease in perfusion pressure and consequent ischemia/hypoxia of the brain tissue. We also propose that the distal areas of the white matter (WM) will be the first affected by a lack of oxygen and nutrients. Our hypotheses are supported by the following observations: (1) the number of stenoses is more frequent in AD than in the control population (p = 0.008); (2) the average index of occlusion is greater in AD than in the control group (p < 0.00001); (3) the index of stenosis and the total number of stenoses per case are positively correlated (R = 0.67); (4) the index of stenosis correlates with the neuropathological lesions of AD and with the MMSE psychometric test; (5) the number and degree of atherosclerosis of the anterior, middle and posterior cerebral arteries is more severe in cases of AD than in the control population; (6) atherosclerosis severity is apparently associated with the severity of the vascular amyloidosis; (7) the WM rarefaction correlates with the severity of the atherosclerosis and vascular amyloidosis; (8) the total cell count and microvessel count in the areas of WM rarefaction correlate with the neuropathological lesions of AD and with the MMSE score. Our data strongly suggest that severe hemodynamic disturbances contribute to sporadic AD and support the numerous observations indicating cardiovascular system participation in the pathogenesis of these dementias.

[1]  D. Coppola,et al.  Inhibition of Angiogenesis by Aβ Peptides , 2004, Angiogenesis.

[2]  W. Markesbery,et al.  Incipient Alzheimer's disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Xianlin Han,et al.  Amyloid-β peptide induces oligodendrocyte death by activating the neutral sphingomyelinase–ceramide pathway , 2004, The Journal of Cell Biology.

[4]  K. Fukuchi,et al.  Association of aortic atherosclerosis with cerebral beta-amyloidosis and learning deficits in a mouse model of Alzheimer's disease. , 2003, The American journal of pathology.

[5]  Thomas G. Beach,et al.  Circle of Willis Atherosclerosis Is a Risk Factor for Sporadic Alzheimer’s Disease , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[6]  Ramón Cacabelos,et al.  Cerebrovascular risk factors in Alzheimer's disease: Brain hemodynamics and pharmacogenomic implications , 2003, Neurological research.

[7]  T. Beach,et al.  Cortical and Leptomeningeal Cerebrovascular Amyloid and White Matter Pathology in Alzheimer’s Disease , 2003, Molecular medicine.

[8]  B. Winblad,et al.  Low blood pressure and risk of dementia in the Kungsholmen project: a 6-year follow-up study. , 2003, Archives of neurology.

[9]  H. Goldsmith Treatment of Alzheimer's Disease by Transposition of the Omentum , 2002, Annals of the New York Academy of Sciences.

[10]  E. Shimosegawa,et al.  Hemodynamic Aspects of Alzheimer's Disease , 2002, Annals of the New York Academy of Sciences.

[11]  I. Skoog,et al.  Hypertension and Related Factors in the Etiology of Alzheimer's Disease , 2002, Annals of the New York Academy of Sciences.

[12]  Jan A Staessen,et al.  The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. , 2002, Archives of internal medicine.

[13]  K. Flegal,et al.  Prevalence and trends in obesity among US adults, 1999-2000. , 2002, JAMA.

[14]  Yu-Min Kuo,et al.  Increased Aβ Peptides and Reduced Cholesterol and Myelin Proteins Characterize White Matter Degeneration in Alzheimer's Disease† , 2002 .

[15]  Arto Mannermaa,et al.  Apolipoprotein E 4 Allele, Elevated Midlife Total Cholesterol Level, and High Midlife Systolic Blood Pressure Are Independent Risk Factors for Late-Life Alzheimer Disease , 2002, Annals of Internal Medicine.

[16]  R. Schmidt,et al.  Early inflammation and dementia: A 25‐year follow‐up of the Honolulu‐Asia aging study , 2002, Annals of neurology.

[17]  L. Launer,et al.  Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. , 2002, Diabetes.

[18]  Sudha Seshadri,et al.  Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease , 2002 .

[19]  L. Launer Demonstrating the case that AD is a vascular disease: epidemiologic evidence , 2002, Ageing Research Reviews.

[20]  Lenore J Launer,et al.  Variability in Midlife Systolic Blood Pressure Is Related to Late-Life Brain White Matter Lesions: The Honolulu-Asia Aging Study , 2002, Stroke.

[21]  H. Soininen,et al.  Hypertension and Hypercholesterolaemia as Risk Factors for Alzheimer’s Disease , 2002, CNS drugs.

[22]  D. Selkoe,et al.  Deciphering the genetic basis of Alzheimer's disease. , 2002, Annual review of genomics and human genetics.

[23]  R. Havlik,et al.  Joint Effect of the APOE Gene and Midlife Systolic Blood Pressure on Late-Life Cognitive Impairment: The Honolulu-Asia Aging Study , 2001, Stroke.

[24]  L. Launer,et al.  Cholesterol and neuropathologic markers of AD , 2001, Neurology.

[25]  R. Mayeux,et al.  Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. , 2001, American journal of epidemiology.

[26]  M. Mercken,et al.  A Cholesterol-Lowering Drug Reduces β-Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease , 2001, Neurobiology of Disease.

[27]  B. Hyman,et al.  Acyl-coenzyme A: cholesterol acyltransferase modulates the generation of the amyloid β-peptide , 2001, Nature Cell Biology.

[28]  D. Sparks,et al.  Cholesterol Accumulates in Senile Plaques of Alzheimer Disease Patients and in Transgenic APPsw Mice , 2001, Journal of neuropathology and experimental neurology.

[29]  H. Soininen,et al.  Midlife vascular risk factors and late-life mild cognitive impairment , 2001, Neurology.

[30]  C. Bergmann,et al.  Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[31]  P Pietrini,et al.  The effect of brain atrophy on cerebral hypometabolism in the visual variant of Alzheimer disease. , 2001, Archives of neurology.

[32]  A. Folsom,et al.  Cardiovascular risk factors and cognitive decline in middle-aged adults , 2001, Neurology.

[33]  J. C. Torre Impaired Cerebromicrovascular Perfusion: Summary of Evidence in Support of Its Causality in Alzheimer's Disease , 2000 .

[34]  Rong Wang,et al.  Hypercholesterolemia Accelerates the Alzheimer's Amyloid Pathology in a Transgenic Mouse Model , 2000, Neurobiology of Disease.

[35]  J. C. Torre Critically attained threshold of cerebral hypoperfusion: can it cause Alzheimer's disease? , 2000 .

[36]  J. C. de la Torre Critically Attained Threshold of Cerebral Hypoperfusion: Can It Cause Alzheimer's Disease? , 2000, Annals of the New York Academy of Sciences.

[37]  J. Hatazawa,et al.  Can PET Data Differentiate Alzheimer's Disease from Vascular Dementia? , 2000, Annals of the New York Academy of Sciences.

[38]  R. Kalaria The role of cerebral ischemia in Alzheimer’s disease , 2000, Neurobiology of Aging.

[39]  W. Markesbery,et al.  Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS☆ , 2000, Neurobiology of Aging.

[40]  R. Havlik,et al.  Midlife blood pressure and dementia: the Honolulu–Asia aging study☆ , 2000, Neurobiology of Aging.

[41]  J. Detre,et al.  Assessment of cerebral blood flow in Alzheimer's disease by spin‐labeled magnetic resonance imaging , 2000, Annals of neurology.

[42]  J. C. Torre,et al.  Cerebral hypoperfusion, capillary degeneration, and development of Alzheimer disease. , 2000 .

[43]  J. C. de la Torre Cerebral hypoperfusion, capillary degeneration, and development of Alzheimer disease. , 2000, Alzheimer disease and associated disorders.

[44]  J. C. de la Torre Impaired cerebromicrovascular perfusion. Summary of evidence in support of its causality in Alzheimer's disease. , 2000, Annals of the New York Academy of Sciences.

[45]  B. Reisberg,et al.  Retrogenesis: clinical, physiologic, and pathologic mechanisms in brain aging, Alzheimer’s and other dementing processes , 1999, European Archives of Psychiatry and Clinical Neuroscience.

[46]  C. Dufouil,et al.  Cognitive decline in individuals with high blood pressure , 1999, Neurology.

[47]  J. Manson,et al.  Annual deaths attributable to obesity in the United States. , 1999, JAMA.

[48]  T. Lehtimäki,et al.  Age-dependent association of apolipoprotein E genotype with coronary and aortic atherosclerosis in middle-aged men: an autopsy study. , 1999, Circulation.

[49]  M. Emmerling,et al.  Amyloid and lipids in the pathology of Alzheimer disease. , 1999, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[50]  M. Emmerling,et al.  Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levels. , 1998, Biochemical and biophysical research communications.

[51]  D. Carmelli,et al.  Systolic blood pressure tracking over 25 to 30 years and cognitive performance in older adults. , 1998, Stroke.

[52]  P F Renshaw,et al.  Dynamic susceptibility contrast MR imaging of regional cerebral blood volume in Alzheimer disease: a promising alternative to nuclear medicine. , 1998, AJNR. American journal of neuroradiology.

[53]  B L Holman,et al.  Preclinical prediction of Alzheimer's disease using SPECT , 1998, Neurology.

[54]  B. Strooper,et al.  Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[55]  L. Hansson,et al.  Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men. , 1998, Hypertension.

[56]  A. Hofman,et al.  Dietary fat intake and the risk of incident dementia in the Rotterdam study , 1997, Annals of neurology.

[57]  J. Trojanowski,et al.  Editorial on Consensus Recommendations for the Postmortem Diagnosis of Alzheimer Disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer Disease , 1997, Journal of neuropathology and experimental neurology.

[58]  H. Goldsmith Omental Transposition to the Brain for Alzheimer's Disease , 1997, Annals of the New York Academy of Sciences.

[59]  L. Pantoni,et al.  Cognitive Impairment and Cellular/Vascular Changes in the Cerebral White Matter a , 1997, Annals of the New York Academy of Sciences.

[60]  R. Vos,et al.  Cerebrovascular Hypoperfusion: A Risk Factor for Alzheimer's Disease? , 1997, Annals of the New York Academy of Sciences.

[61]  S. Mirra The CERAD Neuropathology Protocol and Consensus Recommendations for the Postmortem Diagnosis of Alzheimer’s Disease: A Commentary , 1997, Neurobiology of Aging.

[62]  B. Hyman,et al.  The Neuropathological Diagnosis of Alzheimer’s Disease: Clinical-Pathological Studies , 1997, Neurobiology of Aging.

[63]  N. Foster,et al.  Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease , 1997, Annals of neurology.

[64]  P. Ianna,et al.  Secretory processing of amyloid precursor protein is inhibited by increase in cellular cholesterol content. , 1997, The Biochemical journal.

[65]  M. Bobinski,et al.  Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease , 1997, Neurobiology of Aging.

[66]  S. Kitamura,et al.  [Clinico-pathological evaluation of leukoaraisosis in Alzheimer's disease]. , 1996, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics.

[67]  H. Braak,et al.  Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis , 1996, Acta Neuropathologica.

[68]  B. Lernfelt,et al.  15-year longitudinal study of blood pressure and dementia , 1996, The Lancet.

[69]  W. Klein,et al.  Cholesterol Modulates -Secretase Cleavage of Amyloid Precursor Protein (*) , 1996, The Journal of Biological Chemistry.

[70]  岩本俊彦 Leuko-araiosis と血管性痴呆 , 1996 .

[71]  H. Wiśniewski,et al.  Beta-protein immunoreactivity in the human brain after cardiac arrest. , 1996, Folia neuropathologica.

[72]  T. Scott,et al.  Severe cardiovascular disease and Alzheimer's disease: Senile plaque formation in cortical areas , 1996, Clinical anatomy.

[73]  E F Halpern,et al.  Functional MR in the evaluation of dementia: correlation of abnormal dynamic cerebral blood volume measurements with changes in cerebral metabolism on positron emission tomography with fludeoxyglucose F 18. , 1995, AJNR. American journal of neuroradiology.

[74]  D. Sparks,et al.  Increased incidence of neurofibrillary tangles (NFT) in non-demented individuals with hypertension , 1995, Journal of the Neurological Sciences.

[75]  J. Garcìa,et al.  The significance of cerebral white matter abnormalities 100 years after Binswanger's report. A review. , 1995, Stroke.

[76]  K. Mortel,et al.  Cognitive declines correlate with decreased cortical volume and perfusion in dementia of Alzheimer type , 1994, Journal of the Neurological Sciences.

[77]  K. Flegal,et al.  Increasing Prevalence of Overweight Among US Adults: The National Health and Nutrition Examination Surveys, 1960 to 1991 , 1994 .

[78]  Stephen W. Scheff,et al.  Induction of Alzheimer-like β-Amyloid Immunoreactivity in the Brains of Rabbits with Dietary Cholesterol , 1994, Experimental Neurology.

[79]  N. Lassen,et al.  Heterogeneity of neocortical cerebral blood flow deficits in dementia of the Alzheimer type: a [99mTc]-d,l-HMPAO SPECT study. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[80]  C. Bladin,et al.  Clinical Features, Pathogenesis, and Computed Tomographic Characteristics of Internal Watershed Infarction , 1993, Stroke.

[81]  M J Ball,et al.  beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[82]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[83]  J. Meyer,et al.  Correlations of leuko-araiosis with cerebral atrophy and perfusion in elderly normal subjects and demented patients. , 1993, Journal of neurology, neurosurgery, and psychiatry.

[84]  B. Sahakian,et al.  A study of regional cerebral blood flow and cognitive performance in Alzheimer's disease. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[85]  J. Meyer,et al.  Leukb‐Araiosis and Cerebral Hypoperfusion Compared in Elderly Normals and Alzheimer's Dementia , 1992 .

[86]  J. Meyer,et al.  Leuko-araiosis and cerebral hypoperfusion compared in elderly normals and Alzheimer's dementia. , 1992, Journal of the American Geriatrics Society.

[87]  V. Hachinski,et al.  Improved recognition of leukoaraiosis and cognitive impairment in Alzheimer's disease. , 1991, Archives of neurology.

[88]  V. Hachinski,et al.  Clinical correlates of white-matter changes on magnetic resonance imaging scans of the brain. , 1991, Archives of neurology.

[89]  M. Ball,et al.  Beta-amyloid from Alzheimer disease brains inhibits sprouting and survival of sympathetic neurons. , 1991, Biochemical and biophysical research communications.

[90]  S M Teutsch,et al.  Excess deaths from nine chronic diseases in the United States, 1986. , 1990, JAMA.

[91]  D. Sparks,et al.  Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease , 1990, Neurobiology of Aging.

[92]  H. Morgenstern,et al.  Women, myocardial infarction, and dementia in the very old , 1990, Neurology.

[93]  J. Meyer,et al.  Leukoaraiosis: correlation of MR and CT findings with blood flow, atrophy, and cognition. , 1990, AJNR. American journal of neuroradiology.

[94]  Donald H. Lee,et al.  Neuropathologic correlates of leuko-araiosis. , 1989, Archives of neurology.

[95]  Klaus P. Ebmeier,et al.  Neuroimaging, cognitive, and pathological changes in dementia of the Alzheimer type (DAT) , 1989, Psychiatry Research.

[96]  C. Marini,et al.  Leuko-araiosis: definition and clinical correlates--an overview. , 1989, European neurology.

[97]  H. Sackeim,et al.  Cerebral perfusion as a diagnostic marker of early Alzheimer's disease , 1988, Neurology.

[98]  B. Holman,et al.  Cerebral perfusion imaging in Alzheimer's disease. Use of single photon emission computed tomography and iofetamine hydrochloride I 123. , 1987, Archives of neurology.

[99]  H Merskey,et al.  Leuko-Araiosis: An Ancient Term for a New Problem , 1986, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[100]  A. Brun,et al.  A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study , 1986, Annals of neurology.